Dual-Spectrum Heat Pattern Separation Algorithm For Assessing Chemotherapy Treatment Response And Early Detection

ABSTRACT

It is developed a Dual-Spectrum Heat Pattern Separation (DS-HPS) algorithm to quantify the energy from the area of the high temperature tissues, called q H  map, and decompose the body surface into the high and normal temperature areas based on a pair of middle-wave Infra-red images and long-wave Infra-red images. Further, with longitudinal registration, we can detect the cancerous tissues and assess the chemotherapy treatment response on a pixel by pixel basis according to the change of the q H  map derived by the DS-HPS algorithm. The preliminary result shows the area and the q H  values in the high temperature area are decreased as the patients receive more chemotherapy. These suggest the proposed algorithm could capture the incremental or decremental of the energies emitted by the cancerous tissues, which has the potentials for chemotherapy assessment and early detection.

FIELD OF THE INVENTION

The invention relates to a method for assessing chemotherapy treatment response and early detecting the tumors. More specifically, this invention relates to quantify the energy from high temperature tissues and decompose the body surface into the high and normal temperature area based on a pair of MIR (middle-wave Infra-red) and LIR (long-wave Infra-red) images.

BACKGROUND OF THE INVENTION

Each year, about one million women are diagnosed with breast cancers in the world, which is the second leading cause of death for women. However, it can effectively improve the survival rate of patients by treating tumors at the early stage. Therefore, it is an important issue to detect the breast cancer early for the health of women.

Due to the advantages of non-invasion, non-contact, passivity, non-radiation and the ability of detecting the slight variations of temperature caused by neovascularization, Infrared imaging technique has been developed and employed for assessing chemotherapy treatment response. Serving as a medical imaging modality, the Infra-red (IR) image reveals the heat distribution on the surface of the human body. Cancerous tissues tend to have a higher temperature signature than their surrounding normal tissues, and for this reason, IR image has long been studied in hope to serve as an indicator for cancerous breast tissues. Nevertheless, the usefulness of IR images in detecting breast cancers remains controversial due to the physiological and environmental influence on the skin temperature distribution, and most importantly, there are no objective methods to quantitatively analyze lesion malignancy.

In the prior art, some methods have been reported to detect breast cancers or to assess treatment results of breast cancer chemotherapy using the IR image. These methods can be classified into two general categories, namely cross-sectional and longitudinal approaches. The cross-sectional approaches are mainly based on the comparison between the temperature of the normal area and that of the cancerous area of the breast. Although the breast area with tumors is expected to be higher than that of the normal breast area, it does not necessarily mean that the high temperature area in IR images corresponds to the tumor region (Lawson R., “Implications of surface temperatures in the diagnosis of breast cancer,” Canadian Medical Association Journal, p. 309-310, 1956, Lawson R. N., Chughtai M. S., “Breast Cancer and Body Temperature,” Canadian Medical Association Journal, p. 68-70, 1963 and Stark A. M., Way S., “The use of thermovision in the detection of early breast cancer,” Cancer, p. 1664-1670, 1974). Therefore, it is too arbitrary to use the heat pattern acquired at a single time point as the basis to determine if there is a tumor in a breast.

Alternatively, the longitudinal approaches attempt to determine the malignancy of breast tissues based on the variation of heat pattern over several time points. The general idea is the heat pattern of each person remains roughly unchanged under similar physiological and environmental conditions. It has been observed that the heat patch in the IR image may shrink or even disappear in what seems like a direct correlation to the tumor blood vessels breaking down and eventually disappear as treatment progress (Zylberberg B., Salat-Baroux J., Ravina J. H., et al., “Initial chemoimmunotherapy in inflammatory carcinoma of the breast,” Cancer, p. 1537-1543, 1982). However, a longitudinal approach may have the noisy variations caused by the physiological and environmental factors at different time points. Although the influence of such environmental variables as temperature, humidity, and so on, may be minimized through deliberate control, these factors could still disturb the IR intensity fluctuation and affects the quantitative estimation of IR intensity change along the time. To quantitatively analyze this subjective visual judgment on the change of a breast tumor, each breast is divided into four parts and compared with the temperature distribution of each pair of corresponding parts (Ng E. Y. K., Fok S. C., Peh Y. C., et al., “Computerized detection of breast cancer with artificial intelligence and thermograms,” Journal of Medical Engineering & Technology, p. 152 -157, 2002). The potential deficiency of this approach lies in the fallacious implicit assumption that the two breasts under the normal condition have the same temperature distributions.

In addition, prior to the present invention, the multiple-spectrum IR information is employed in a longitudinal approach at the same time in order to detect and quantify the breast cancer information collected under minimal physiological and environmental effects. By combining different energies received in the IR images of different spectrums, this approach offers an opportunity to further reduce the influence of the physiological and environmental factors. The blind source separation algorithm using two satellite-grade infrared cameras demonstrated that it is likely to detect breast cancer based on a pair of MIR and LIR breast images (Szu H., Miao L. and Qi H., “Thermodynamic free-energy minimization for unsupervised fusion of dual-color infrared breast images,” SPIE, Florida, 2006). Since this algorithm mainly counts on the minute difference between the vectors, i.e., (MIR, LIR), of the cancerous and normal tissues, further investigation is required to attain a sufficient signal-to-noise ratio for this idea to be applied in a clinical setting.

In present, there are some indexes are utilized in the clinical to assess the effect of the chemotherapy treatment:

1. Positron Emission Tomography (PET) Quantitative Index: Standardized Uptake Value (SUV)

18F-fluorodeoxyglucose (18F-FDG) is the most common positron indicator. It can observe the metabolism of glucose in the organism and monitor the effect of the treatment. If the high chemotherapy susceptibility tumor undergoes one to two times of the course of treatments, the intake of the FDG will significant decrease, or even inhibit completely. It is important for evaluating the effect of the treatment in the early stage of the course of treatment, because it can avoid the toxic and the side effect triggered by the ineffective treatment to select another treatment in an early. The PET also can utilize in evaluating the prognosis of the patient. If the intake of the FDG is strong, it usually represents that the tumor is aggressive and fast growth. If the chemotherapy is effective, the SUV quantitative index will be increased with the frequency of the chemotherapy received by the patient, which let the metabolism of the glucose decreased, to preliminary assess the response of the chemotherapy.

2. Vascularity Score

In the histological section of the tumor cell, it is found that the neovascularization in the tumor cell is much more than that in the normal cell. Therefore, if the chemotherapy is effective, the vascularity quantitative index will be increased with the frequency of the chemotherapy received by the patient, which let the blood vessels around the tumor become atrophy and vanishment, to preliminary assess the response of the chemotherapy.

3. Tumor Size

In evaluating the chemotherapy effective of the solid tumor, the easily observed and the most important index is the tumor size. The longest diameter of the tumor is A, the longest diameter of the right angle of the tumor is B, then A times B is the tumor area. The longest diameter of the tumor after curing is a, the longest diameter of the right angle of the tumor after curing is b, then a times b is the tumor area after curing. The effective of treatment is evaluated according to the ratio of the tumor area before and after the treatment.

(1) complete response (CR): the tumor disappear completely at least one month.

(2) partial response: the ratio of ab/AB is less than 50%, and does not produce new lesion at least one month.

(3) stable disease: the ratio of ab/AB is between 50%˜125%, and the tumor does not have substantially progression.

(4) disease progression: the ratio of ab/AB is more than 125%, or produce new lesion.

If the chemotherapy is effective, the size of the tumor index will be increased with the frequency of the chemotherapy received by the patient, which let the volume of the tumor decreased, to preliminary assess the response of the chemotherapy.

According to the present invention, applicants have departed from the conventional wisdom, and had conceived and implemented a new longitudinal approach to estimate the heat pattern change on the breast skin with IR photon information from a pair of MIR and LIR cameras, rather than directly estimating the likelihood that each pixel contains cancerous tissue. In addition, since the image of the MIR and LIR cameras has characteristics of radiationless, non-invasive and low cost, the process of the chemotherapy can be long-term traced and repeatedly shot. Hence, the shooting times of the IR image are more than twice comparing with other clinic detection methods in the chemotherapy treatment, which let the treatment effect can be assessed more thoroughly. Furthermore, in the situation of more intensive tracing, the pros and cons of the effect of chemotherapy can be responded in advance, to assist the medication of a doctor, and also can be an another reference method provided to the patient. In summary, the effects of chemotherapy on breast cancer are effectively traced and evaluated by using this method, and the qH index can be one of auxiliary parameters for the effect of the chemotherapy treatment. The invention is briefly described as follows.

SUMMARY OF THE INVENTION

To minimize these effects of physiological and environmental factors effectively, the present invention provides a new and useful quantitative analysis method used to achieve the quantitative assessment of chemotherapy and detect the locations of tumors.

The quantitative analysis method of the present invention is to estimate the emitted energies of the high temperature area on the body surface from a pair of MIR and LIR cameras. A dual-spectrum heat pattern separation (DS-HPS) algorithm is developed to quantify the energy from high temperature tissues, denoted as a q_(H) map, and decompose the body surface into the high and normal temperature area based on a pair of MIR and LIR images. Two descriptors are computed to indicate the structural and functional change of the tissues due to chemotherapy. One is the area of the high temperature region on the body surface and the other is the energies of high temperature tissues under the high temperature region. Increasing or decreasing of these two descriptors may indicate the location of tumors and effectiveness of chemotherapy, respectively. Such an analysis method to quantify the energy map makes the invented algorithm extremely suitable for testing the human body applications including non-invasive detection of human body, assessing chemotherapy treatment response, early detection and etc.

In accordance with one aspect of the present invention, a quantitative analysis method is provided. The quantitative analysis method includes the following steps of:

(a) obtaining an energy reading vector of a corresponding point pair in an LIR image and an MIR image;

(b) establishing a cost function for the quantitative analysis method;

(c) deriving evolution equations; and

(d) estimating an optimal q_(H) map.

Preferably, the energy reading vector is the LIR and MIR energy emitted from an unit volume of a high and a normal temperature tissue, respectively;

Preferably, the q_(H) map is the energy distribution of the high temperature tissue.

Preferably, the q_(H) map could be used to distinguish a high temperature tissue from a normal temperature tissue.

The above aspects and advantages of the present invention will become more readily apparent to those ordinarily skilled in the art after reviewing the following detailed descriptions and accompanying drawings, in which:

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows that the software framework diagram of the present invention for obtaining energies distribution maps;

FIG. 2 contains evolution equations for a dual-spectrum heat pattern separation (DS-HPS) algorithm in the present invention;

FIGS. 3( a) and (b) is a pair of original middle-wave Infra-red (MIR) and long-wave Infra-red (LIR) images of a patient taken by MIR and LIR cameras, respectively;

FIGS. 4( a) and (b) gives the MIR and LIR images, respectively, and FIG. 4( c) demonstrates the registered MIR image; and

FIG. 5 shows the results of the DS-HPS algorithm of MIR and LIR images taken in a sequence of chemotherapy, wherein FIG. 5( a) is the results of the proposed approach for a sequence of chemotherapy, FIG. 5( b) represents the area of the high temperature region (HT-area) curve and FIG. 5( c) represents the energy originated from the high temperature tissues (HT-E) curves of five selected regions of interest (ROIs).

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

The present invention will now be described more specifically with reference to the following embodiments. It is to be noted that the following descriptions of preferred embodiments of this invention are presented herein for the purposes of illustration and description only it is not intended to be exhaustive or to be limited to the precise form disclosed.

Please refer to FIG. 1, which shows a quantitative q_(H) map being output in order to assess the chemotherapy response and detect the cancerous tissue through the present invention. As described in FIG. 1, the registration method 101 was used to obtain the registered image 102 in a MIR image 1001 and a LIR image 1002, and then DS-HPS algorithm 103 could obtain the quantitative q_(H) and q_(N) maps 104 to analyze the registered image 102. Preferably, the MIR image 1001 and the LIR image 1002 are obtained from a pair of MIR and LIR cameras. Preferably, the DS-HPS algorithm 103 uses a Blind Source Separation (BSS) concept to estimate the energy map (q_(H) and q_(N)) of the high temperature area and the normal temperature area. As a result, the longitudinal variations of the area and the q_(H) values in the high temperature area and its surrounding blood vessels could be computed from the quantitative q_(H) map 104 to indicate the location of tumors and effectiveness of chemotherapy, since the cancerous tissues tend to have a higher temperature than the surrounding normal tissues.

Please refer to FIG. 2, which shows that the cost function and evolution equations of the DS-HPS algorithm in the present invention. The DS-HPS algorithm is formulated as a blind source separation (BSS) algorithm. Let x=(χ_(L), χ_(M)) be the energy reading vector of a corresponding point pair in the LIR and MIR images. Suppose M_(N) and M_(H) represents the MIR energy emitted from one unit volume of a normal and a high temperature tissue, respectively. Similarly, suppose L_(N) and L_(H) represents the LIR energy emitted from one unit volume of a normal and a high temperature tissue, respectively. Moreover, let k_(N) and k_(H) be the effective volume of the normal temperature tissue and the high temperature tissue, respectively. Note that the effective volume is not equivalent to the actual volume. The effective volume takes into account the energy attenuation during the propagation from the IR photon generation site to the breast surface. The energies detected by the LIR and MIR cameras may be approximated as a linear composition of the energies of the attenuated LIR and MIR photons originated from the high temperature and normal temperature tissues as follows:

$\begin{matrix} {\begin{bmatrix} x_{L} \\ x_{M} \end{bmatrix} = {\begin{bmatrix} L_{H} & L_{N} \\ M_{H} & M_{N} \end{bmatrix}\begin{bmatrix} k_{H} \\ k_{N} \end{bmatrix}}} & (1) \end{matrix}$

If we let L_(H)=A_(H) cos θ, M_(H)=A_(H) sin θ, L_(N)=A_(N) cos Φ and M_(N)=A_(N) sin Φ, equation (1) can be represented as:

$\begin{matrix} {\begin{bmatrix} x_{L} \\ x_{M} \end{bmatrix} = {\begin{bmatrix} {\cos \mspace{14mu} \theta} & {\cos \mspace{14mu} \varphi} \\ {\sin \mspace{14mu} \theta} & {{in}\mspace{14mu} \varphi} \end{bmatrix}\begin{bmatrix} q_{H} \\ q_{N} \end{bmatrix}}} & (2) \end{matrix}$

where q_(H)=A_(H)k_(H) and q_(N)=A_(N)k_(N).q_(H) and q_(N) may be considered as the quantity approximately equivalent to the energies of the attenuated LIR and MIR photons originated from the high temperature tissue and the normal temperature tissue, respectively, and θ and Φ are respectively the parameters of the high temperature and the normal temperature of the detected body region.

There are 4 unknowns in equation (2) but with only 2 equations. To solve this dilemma, it is assumed that the parameter Φ and q_(N) change slowly in the normal temperature region. Based on these two assumptions, the cost function 200 of this algorithm may be formulated as:

$\begin{matrix} {{f = {A + B + C + D + {\lambda \left\lbrack {q_{N} - q_{N\; 0}} \right\rbrack}^{2}}}{{{wherein}\mspace{14mu} f} = {A + B + C + D + {\lambda \left\lbrack {q_{N} - q_{N\; 0}} \right\rbrack}^{2}}},{A = \left\lbrack {X_{L} - \left( {{\cos \mspace{14mu} {\theta \cdot q_{H}}} + {\cos \mspace{14mu} {\varphi \cdot q_{N}}}} \right)} \right\rbrack^{2}},{B = \left\lbrack {X_{M} - \left( {{\sin \mspace{14mu} {\theta \cdot q_{H}}} + {\sin \mspace{14mu} {\varphi \cdot q_{N}}}} \right)} \right\rbrack^{2}},{C = {\alpha_{H}^{2}\left\lbrack {\left( \frac{\partial q_{H}}{\partial x} \right)^{2} + \left( \frac{\partial q_{H}}{\partial\gamma} \right)^{2}} \right\rbrack}},{D = {\alpha_{N}^{2}\left\lbrack {\left( \frac{\partial q_{N}}{\partial x} \right)^{2} + \left( \frac{\partial q_{N}}{\partial y} \right)^{2}} \right\rbrack}},} & (3) \end{matrix}$

C and D are the smoothness constraint, q_(N) ₀ represents the initial q_(N), and λ is the Lagrange multiplier.

The evolution equations for q_(N) and q_(H) may be derived as follows:

$\begin{matrix} {{q_{N}^{n + 1} = \frac{\begin{matrix} {\left\{ {\left\lbrack {{\alpha_{H}{\overset{\_}{q}}_{H}^{n}} + \left( {{X_{L}\mspace{14mu} \cos \mspace{14mu} \theta} + {X_{M}\mspace{14mu} \sin \mspace{14mu} \theta}} \right)} \right\rbrack {\cos \left( {\theta - \varphi} \right)}} \right\} -} \\ {\left\lbrack {{\alpha_{N}{\overset{\_}{q}}_{N}^{n}} + \left( {{X_{L}\mspace{14mu} \cos \mspace{14mu} \varphi} + {X_{M}\mspace{14mu} \sin \mspace{14mu} \varphi}} \right) + {\lambda q}_{N\; 0}} \right\rbrack \left( {1 + \alpha_{H}} \right)} \end{matrix}}{{\cos^{2}\left( {\theta - \varphi} \right)} - {\left( {1 + \alpha_{H}} \right)\left( {1 + \alpha_{N} + \lambda} \right)}}}{q_{H}^{n + 1} = \frac{\begin{matrix} {\left. {\left\{ {{\alpha_{N}{\overset{\_}{q}}_{N}^{n}} + \left( {{X_{L}\mspace{14mu} \cos \mspace{14mu} \varphi} + {X_{M}\mspace{14mu} \sin \mspace{14mu} \varphi}} \right) + {\lambda \; q_{N\; 0}}} \right\rbrack {\cos \left( {\theta - \varphi} \right)}} \right\} -} \\ {\left\lbrack {{\alpha_{H}{\overset{\_}{q}}_{H}^{n}} + \left( {{X_{L}\mspace{14mu} \cos \mspace{14mu} \theta} + {X_{M}\mspace{14mu} \sin \mspace{14mu} \theta}} \right)} \right\rbrack \left( {1 + \alpha_{N} + \lambda} \right)} \end{matrix}}{{\cos^{2}\left( {\theta - \varphi} \right)} - {\left( {1 + \alpha_{H}} \right)\left( {1 + \alpha_{N} + \lambda} \right)}}}} & (4) \end{matrix}$

the q_(H) map is thresholded in such a way that all values smaller than 0.001 are to 0. The high temperature region is then defined by the remaining nonzero pixels in the q_(H) map.

Please refer to FIGS. 3( a) and (b), which is a pair of original MIR and LIR images of a patient taken by MIR and LIR cameras, respectively. On the right side of each IR image there is a color reference gauge for pseudo-coloring.

Please refer to FIG. 4, in which FIGS. 4( a) and (b) are the MIR and the LIR image, respectively, and FIG. 4( c) demonstrates the registered image via a registration method.

Please refer to FIG. 5, which presents the results of the DS-HPS algorithm for 5 pairs of MIR and LIR images taken in a sequence of chemotherapy. Two dates are shown on top of each column. The date on the row “IR” is the date when IR images were taken, and “chemo” is the chemotherapy day. Columns from top to bottom represent ROIs and q_(H) maps respectively. If the effectiveness of the chemotherapy is assessed by observing only MIR or LIR images as shown in the ROI row of FIG. 5( a), it is obviously difficult to determine the change of the lesion size and its peripheral vessels quantitatively. In addition, we cannot estimate the variation of energy emitted from the cancerous tissues. However, the q_(H) map in the last row of FIG. 5( a) clearly shows the structural change of cancerous tissues as well as the variation of energy detected from cancerous tissues. The two descriptors, i.e., HT-area and HT-E, are plotted in FIG. 5( b) and (c). HT-area shows a decreasing trend in the overall high temperature area, consistent with the reduced tumor size as confirmed by the MRI, Ultrasound and Mammogram. The tumor location is L11/4-12/3-1/4 (11:30 to 13:00 of the left breast, 3 to 4 cm from the nipple) and the tumor size is about 2 cm×4 cm. After chemotherapy, the tumor size becomes 0.9 cm×3 cm. Based on the HT-area result, five small ROIs are selected in each q_(H) map for further estimate the probability of tumor in these locations and assess the response to chemotherapy. FIG. 5( c) shows the HT-E descriptor of five red areas. The HT-E curves of line 4 and line 5 show an obvious decreasing trend, consistent with the reduced tumor size as confirmed by the MRI result. It could be inferred that there might be tumors in the 4th and 5th locations of the infrared image due to energy decrease after chemotherapy. There is also a decreasing trend in HT-E curve of line 3 because the 3rd location is near the 4th location. The rising and oscillation of HT-E curves of line 1 and line 2 indicate the small probability of tumor in these locations.

In conclusion, the DS-HPS algorithm is proposed in the present invention for quantitative assessment of chemotherapy and early detection. The proposed DS-HPS algorithm identifies the high temperature region, as well estimates the energy of the attenuated LIR and MIR photons originated from the high temperature tissue and the normal temperature tissue, respectively. These two descriptors have been devised to quantify the change of the cancerous tissues, including the lesion size and peripheral vessel structures as well as the variation of the emitted energy. The result shows that the proposed approach has the potential for quantitative assessment of chemotherapy and indicating the locations of tumors.

Based on the above descriptions, it is understood that the present invention is indeed an industrially applicable, novel and obvious one with values in industrial development. While the invention has been described in terms of what are presently considered to be the most practical and preferred embodiment, it is to be understood that the invention should not be limited to the disclosed embodiment. On the contrary, it is intended to cover numerous modifications and variations included within the spirit and scope of the appended claims which are to be accorded with the broadest interpretation so as to encompass all such modifications and variations. Therefore, the above description and illustration should not be taken as limiting the scope of the present invention which is defined by the appended claims. 

1. A method for assessing a chemotherapy treatment, comprising steps of: obtaining an energy reading vector of a corresponding point pair in long-wave Infra-red (LIR) image and middle-wave Infra-red (MIR) image; and using a Dual-Spectrum Heat Pattern Separation (DS-HPS) algorithm to calculate, based on the energy reading vector, a q_(H) map as an indicator for assessing an effect of the chemotherapy treatment.
 2. The method as claimed in claim 1 further comprising a step of quantitatively analyzing the q_(H) map into a high temperature region (HT-Area) and a high temperature energy (HT-E) originated from a high temperature tissue in a body region, wherein the q_(H) map, the HT-Area and the HT-E are utilized to assess the effect of the chemotherapy treatment.
 3. The method as claimed in claim 1, wherein the vector X is the energy reading vector approximated by the following equation (I): $\begin{matrix} {X = {\begin{bmatrix} x_{L} \\ x_{M} \end{bmatrix} = {\begin{bmatrix} L_{H} & L_{N} \\ M_{H} & M_{N} \end{bmatrix}\begin{bmatrix} k_{H} \\ k_{N} \end{bmatrix}}}} & (I) \end{matrix}$ , where X=(χ_(L), χ_(M)) being the energy reading vector of a corresponding point pair in the LIR and the MIR images, (L_(N), M_(N)) respectively represents a LIR and a MIR energy emitted from an unit volume of a normal temperature tissue, (L_(H), M_(H)) represents the LIR and MIR energy emitted from the unit volume of the high temperature tissue, and k_(H) and k_(N) are two effective volumes of the high temperature tissue and the normal temperature tissue respectively.
 4. The method as claimed in claim 3, wherein the energy reading vector further is represented as: ${X = {\begin{bmatrix} x_{L} \\ x_{M} \end{bmatrix} = {\begin{bmatrix} {\cos \mspace{14mu} \theta} & {\cos \mspace{14mu} \varphi} \\ {\sin \mspace{14mu} \theta} & {\sin \mspace{14mu} \varphi} \end{bmatrix}\begin{bmatrix} q_{H} \\ q_{N} \end{bmatrix}}}},$ by letting L_(H)=A_(H) cos θ, M_(H)=A_(H) sin θ, L_(N)=A_(N) cos Φ, M_(N)=A_(N) sin Φ, q_(H)=A_(H)k_(H) and q_(N)=A_(N)k_(N), and by considering q_(H) and q_(N) as quantities approximately equivalent to the energies of the attenuated LIR and MIR photons originated from the high temperature tissue and the normal temperature tissue in the body region, and θ and Φ are respectively parameters of the high temperature and the normal temperature.
 5. The method as claimed in claim 4, wherein the body region is a part of body with tumors and its surrounding areas which reveals a heat pattern on a body skin, and the two effective volumes k_(N) and k_(H), which take into account the energy attenuation during the propagation from an IR photon generation site to a body surface, are not equivalent to an actual volume.
 6. The method as claimed in claim 4, further comprising a step of deriving evolution equations for the q_(N) and the q_(H).
 7. The method as claimed in claim 6, further comprising a step of using the evolution equations to estimate the q_(H) map from a cost function.
 8. The method as claimed in claim 7, wherein the cost function, ƒ, for the quantitative analysis is: ${f = {A + B + C + D + {\lambda \left\lbrack {q_{N} - q_{N\; 0}} \right\rbrack}^{2}}},{{{where}\mspace{14mu} f} = {A + B + C + D + {\lambda \left\lbrack {q_{N} - q_{N\; 0}} \right\rbrack}^{2}}},{A = \left\lbrack {X_{L} - \left( {{\cos \mspace{14mu} {\theta \cdot q_{H}}} + {\cos \mspace{14mu} {\varphi \cdot q_{N}}}} \right)} \right\rbrack^{2}},{B = \left\lbrack {X_{M} - \left( {{\sin \mspace{14mu} {\theta \cdot q_{H}}} + {{in}\mspace{14mu} {\varphi \cdot q_{N}}}} \right)} \right\rbrack^{2}},{C = {\alpha_{H}^{2}\left\lbrack {\left( \frac{\partial q_{H}}{\partial x} \right)^{2} + \left( \frac{\partial q_{H}}{\partial\gamma} \right)^{2}} \right\rbrack}},{D = {\alpha_{N}^{2}\left\lbrack {\left( \frac{\partial q_{N}}{\partial x} \right)^{2} + \left( \frac{\partial q_{N}}{\partial y} \right)^{2}} \right\rbrack}},$ where (x_(L), X_(M)) is the energy reading vector of a corresponding point pair in the LIR and MIR images, C and D are smoothness constraints, q_(N) ₀ represents an initial state of the q_(N), and λ is a Lagrange multiplier.
 9. The method as claimed in claim 8, wherein the evolution equations for the q_(N) and the q_(H) are: $q_{N}^{n + 1} = \frac{\begin{matrix} {\left\{ {\left\lbrack {{\alpha_{H}{\overset{\_}{q}}_{H}^{n}} + \left( {{X_{L}\mspace{14mu} \cos \mspace{14mu} \theta} + {X_{M}\mspace{14mu} \sin \mspace{14mu} \theta}} \right)} \right\rbrack {\cos \left( {\theta - \varphi} \right)}} \right\} -} \\ {\left\lbrack {{\alpha_{N}{\overset{\_}{q}}_{N}^{n}} + \left( {{X_{L}\mspace{14mu} \cos \mspace{14mu} \varphi} + {X_{M}\mspace{14mu} \sin \mspace{14mu} \varphi}} \right) + {\lambda q}_{N\; 0}} \right\rbrack \left( {1 + \alpha_{H}} \right)} \end{matrix}}{{\cos^{2}\left( {\theta - \varphi} \right)} - {\left( {1 + \alpha_{H}} \right)\left( {1 + \alpha_{N} + \lambda} \right)}}$ $q_{H}^{n + 1} = {\frac{\begin{matrix} {\left. {\left\{ {{\alpha_{N}{\overset{\_}{q}}_{N}^{n}} + \left( {{X_{L}\mspace{14mu} \cos \mspace{14mu} \varphi} + {X_{M}\mspace{14mu} \sin \mspace{14mu} \varphi}} \right) + {\lambda \; q_{N\; 0}}} \right\rbrack {\cos \left( {\theta - \varphi} \right)}} \right\} -} \\ {\left\lbrack {{\alpha_{H}{\overset{\_}{q}}_{H}^{n}} + \left( {{X_{L}\mspace{14mu} \cos \mspace{14mu} \theta} + {X_{M}\mspace{14mu} \sin \mspace{14mu} \theta}} \right)} \right\rbrack \left( {1 + \alpha_{N} + \lambda} \right)} \end{matrix}}{{\cos^{2}\left( {\theta - \varphi} \right)} - {\left( {1 + \alpha_{H}} \right)\left( {1 + \alpha_{N} + \lambda} \right)}}.}$
 10. The method as claimed in claim 9, wherein the q_(H) map is thresholded in such a way that all values of the cost function smaller than 0.001 are set to
 0. 11. The method as claimed in claim 1, wherein the q_(H) map is an energy distribution map to show the emitted energy from the high temperature tissue.
 12. The method as claimed in claim 1 further comprising a step of using a spatiotemporal registration algorithm to register the LIR and the MIR images.
 13. The method as claimed in claim 1, wherein the LIR and the MIR images are images taken at one of a time before and a time after the chemotherapy treatment.
 14. A method for assessing a chemotherapy treatment response, comprising steps of: obtaining a first q_(H) map before the chemotherapy treatment; obtaining a second q_(H) map after the chemotherapy treatment; and comparing the first q_(H) map and the second q_(H) map to assess an effect of the chemotherapy treatment.
 15. The method as claimed in claim 14, wherein the first and the second q_(H) maps are calculated by a Dual-Spectrum Heat Pattern Separation (DS-HPS) algorithm, wherein the q_(H) map is an energy distribution map to show an emitted energy from a high temperature tissue.
 16. The method as claimed in claim 14, further comprising a step of quantitatively analyzing the q_(H) map into a high temperature region (HT-Area) and a high temperature energy (HT-E) originated from a high temperature tissues in a body region.
 17. The method as claimed in claim 16, wherein the q_(H) map, the HT-Area and the HT-E of the high temperature tissue are used to assess the effect of the chemotherapy treatment and further to detect where the tumor is. 